Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Shuster

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|June 25, 1998
Myeloperoxidase gene expression in infant leukemia: a Pediatric Oncology Group StudyC S Alvarado, G E Austin, M J Borowitz, et al.
Leukemia|May 1, 1992
Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group studyT C Abshire, G R Buchanan, J F Jackson, et al.
Leukemia|January 1, 1990
Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: implications for clinical trialsM P Sullivan, D J Pullen, W M Crist, et al.
Leukemia|July 18, 2001
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trialS J Lauer, J J Shuster, D H Mahoney, et al.
Medical and Pediatric Oncology|March 1, 1995
Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II studyN B McWilliams, F A Hayes, A A Green, et al.
Cancer|April 15, 1992
Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Leukemia & Lymphoma|November 9, 2001
Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group studyJ H Laver, H Mahmoud, T E Pick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposideN J Winick, R W McKenna, J J Shuster, et al.
Computer Methods and Programs in Biomedicine|August 1, 1993
Management of cytogenetic data in multi-center leukemia trialsJ J Shuster, A J Carroll, T A Look, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology GroupM J Borowitz, A J Carroll, J J Shuster, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|June 25, 1998
Myeloperoxidase gene expression in infant leukemia: a Pediatric Oncology Group StudyC S Alvarado, G E Austin, M J Borowitz, et al.
Leukemia|May 1, 1992
Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group studyT C Abshire, G R Buchanan, J F Jackson, et al.
Leukemia|January 1, 1990
Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: implications for clinical trialsM P Sullivan, D J Pullen, W M Crist, et al.
Leukemia|July 18, 2001
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trialS J Lauer, J J Shuster, D H Mahoney, et al.
Medical and Pediatric Oncology|March 1, 1995
Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II studyN B McWilliams, F A Hayes, A A Green, et al.
Cancer|April 15, 1992
Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Leukemia & Lymphoma|November 9, 2001
Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group studyJ H Laver, H Mahmoud, T E Pick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposideN J Winick, R W McKenna, J J Shuster, et al.
Computer Methods and Programs in Biomedicine|August 1, 1993
Management of cytogenetic data in multi-center leukemia trialsJ J Shuster, A J Carroll, T A Look, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology GroupM J Borowitz, A J Carroll, J J Shuster, et al.
Pageof 16